Autopsy report · NCT00410150

Heliox-Powered Albuterol Therapy in the Treatment of Children Admitted With Acute Asthma Exacerbation

“Study was stopped after interim analysis and slow enrollment.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 8 months after it had already started.
• Ran for about 1 year 8 months before it stopped.
• 42 participants enrolled.
• Results were posted on the registry 2 years 10 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Children's Hospital Medical Center, Cincinnati

Sponsor type

University, hospital or other

Conditions

Status Asthmaticus

Interventions

Helium-oxygen-driven albuterol nebulizer; Oxygen

Participants

42

Sites

1

Countries

United States

Trials that died the same way

• A Comparison of Surgical Preparations and Wound Infection Rates for Elective Cesarean Sections
  “Study was stopped following interim analysis.” (89% match in meaning)
• Dabrafenib, Trametinib, and Spartalizumab for the Treatment of BRAF V600E or V600K Mutation Positive Stage IIIB/C/D Melanoma
  “Study stopped due to slow enrollment” (86% match in meaning)
• Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer
  “The study was halted because enrollment was too slow” (85% match in meaning)
• Hand Injected Ventriculography vs. Power Injected Left Ventriculography
  “Study was stopped due to low enrollment.” (84% match in meaning)
• The Role of Osteopathic Manipulative Medicine in Recovery From Concussions
  “Due to lower than anticipated enrollment number, this study was stopped.” (84% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.